Quantcast

Latest Drug safety Stories

2014-06-16 12:28:52

ATLANTA, June 16, 2014 /PRNewswire/ -- Avion Pharmaceuticals, LLC, a specialty pharmaceutical company, announces positive feedback on two New Drug Applications (NDA) with projected approvals of late 2016 and early 2017. Based on the feedback from the Food and Drug Administration (FDA) Avion will be moving into Phase II/III on one NDA Program, and into Phase II on the other. In line with Avion's strategic corporate mission, both NDAs are in the women's health category. "We are very...

2014-06-11 23:11:20

Important sub-sector of medicine is critical in education. (PRWEB) June 11, 2014 From refilling prescriptions to making sure two different medications do not interfere with one another, pharmacists play an important role in the lives of millions of Americans. However, from behind the counter it simply looks like the workers are simply filling medication containers and that is it. The truth is, these highly educated and trained professionals do much more than this, and understanding what...

2014-06-10 08:31:44

MOMENCE, Ill., June 10, 2014 /PRNewswire/ -- In a recent comment on the FDA's Guidance for Determining Whether Human Research Studies Can Be Conducted Without an Investigational New Drug Application (IND) (79 Fed. Reg. 7204. Docket FDA-2010-D-0503), FutureCeuticals expressed its strong support for gold-standard, peer-reviewed clinical research on food and dietary ingredients and urged the FDA to properly supervise any clinical research on food or dietary ingredients under the purview...

2014-06-03 23:00:56

Chris Geiger, author of “The Cancer Survivors Club”, and Dr. Fergus Sweeney, Head Inspections and Human Medicines Pharmacovigilance Division at the European Medicines Agency, will keynote the PhUSE Annual Conference in London, UK in October 2014. (PRWEB) June 04, 2014 PhUSE is proud to announce Chris Geiger and Dr. Fergus Sweeney as keynote speakers for their 10th annual conference which is themed “Data Transparency”. Following keynotes from Dr. Ben Goldacre in 2013, Charles...

2014-05-30 23:03:07

Narconon Freedom Center raises awareness of the dangers of prescription drugs during National Safety Month. Albion, MI (PRWEB) May 30, 2014 The National Safety Council sponsors the month of June as National Safety Month. As part of the U.S Department of Health and Human Services (HHS), the National Safety Council cites injuries as a leading cause of disability for Americans of all ages, as well as a leading cause of death for those aged 1 to 44. The agency also notes that many injuries...

2014-05-28 23:13:22

There are ways to save money on Over The Counter medicines and products according to Ace Innovation Group. Rock Hill, South Carolina (PRWEB) May 28, 2014 Wide variety of Over The Counter medicines and products are available and prices vary from just a couple of dollars to almost four or five times that. So how does one save money on OTC medicines and products? Consumers are becoming smarter and they can take advantage of serious price differences if they know where to look. Here are some...

2014-05-19 08:29:19

Scilex has commenced with its pivotal bioequivalence study of Ztilido versus Lidoderm® in accordance with FDA recommendations to support approval of Ztilido submitted as a 505(b)(2) NDA MALVERN, Pa., May 19, 2014 /PRNewswire/ -- SCILEX Pharmaceuticals, Inc., a company engaged in the development and commercialization of late-stage pharmaceutical products focused on the treatment of pain, announced today that it has initiated a pivotal pharmacokinetic (PK) study of its investigational...

2014-05-16 08:26:43

CUPERTINO, Calif., May 16, 2014 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that data for POSIDUR((TM)) (SABER(®)-Bupivacaine), an investigational drug for administration into the surgical site to produce post-surgical analgesia, is being presented at the International Anesthetic Research Society (IARS) Annual Meeting. The meeting will be held on May 17-20 at the Fairmont Queen Elizabeth Hotel in Montreal. "Bupivacaine is a widely used local anesthetic...

2014-05-12 23:07:22

Important webinar to examine the first regulatory year of EU regulations regarding cosmetovigilance. The live broadcast takes place on Thursday, June 5, 2014 at 11:00am EDT (16:00 UK BST/ GMT +1). Toronto, Canada (PRWEB) May 12, 2014 The first anniversary is approaching for European regulations for mandatory reporting of serious adverse events temporally related to cosmetic use. Reporting of these events is often complicated by a product’s status as drug in one region, but a cosmetic in...

2014-05-08 23:08:58

Introducing eCongress on Pharmacovigilance, a new webinar series taking place throughout May to June 5th. The online series, which is free to attend, will provide professionals and practitioners gain current insight on drug safety monitoring, regulatory affairs and safety issues with prominent leaders of the industry. Toronto, Canada (PRWEB) May 08, 2014 During the series, featured speakers will share their perspectives and insights on key topics such as information management and...


Word of the Day
attercop
  • A spider.
  • Figuratively, a peevish, testy, ill-natured person.
'Attercop' comes from the Old English 'atorcoppe,' where 'atter' means 'poison, venom' and‎ 'cop' means 'spider.' 'Coppa' is a derivative of 'cop,' top, summit, round head, or 'copp,' cup, vessel, which refers to 'the supposed venomous properties of spiders,' says the OED. 'Copp' is still found in the word 'cobweb.'
Related